| pubmed-article:407151 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:407151 | lifeskim:mentions | umls-concept:C0700364 | lld:lifeskim |
| pubmed-article:407151 | lifeskim:mentions | umls-concept:C0205419 | lld:lifeskim |
| pubmed-article:407151 | lifeskim:mentions | umls-concept:C0011799 | lld:lifeskim |
| pubmed-article:407151 | pubmed:issue | 4 | lld:pubmed |
| pubmed-article:407151 | pubmed:dateCreated | 1977-9-22 | lld:pubmed |
| pubmed-article:407151 | pubmed:abstractText | MOPC 104E is a mouse plasmacytoma which produces an IgM (lambda) myeloma protein. This IgM protein has a binding specificity for dextran B-135s. This report describes a variant of the MOPC 104E tumor which secretes a myeloma protein which does not react with the dextran. The apparent variant of MOPC 104E arose spontaneously during routine passage of the MOPC 104E tumors in Balb/C mice and appears to be stable. | lld:pubmed |
| pubmed-article:407151 | pubmed:language | eng | lld:pubmed |
| pubmed-article:407151 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:407151 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:407151 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:407151 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:407151 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:407151 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:407151 | pubmed:issn | 0090-0877 | lld:pubmed |
| pubmed-article:407151 | pubmed:author | pubmed-author:FoldsJ DJD | lld:pubmed |
| pubmed-article:407151 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:407151 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:407151 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:407151 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:407151 | pubmed:pagination | 385-94 | lld:pubmed |
| pubmed-article:407151 | pubmed:dateRevised | 2008-11-21 | lld:pubmed |
| pubmed-article:407151 | pubmed:meshHeading | pubmed-meshheading:407151-A... | lld:pubmed |
| pubmed-article:407151 | pubmed:meshHeading | pubmed-meshheading:407151-M... | lld:pubmed |
| pubmed-article:407151 | pubmed:meshHeading | pubmed-meshheading:407151-D... | lld:pubmed |
| pubmed-article:407151 | pubmed:meshHeading | pubmed-meshheading:407151-G... | lld:pubmed |
| pubmed-article:407151 | pubmed:meshHeading | pubmed-meshheading:407151-P... | lld:pubmed |
| pubmed-article:407151 | pubmed:meshHeading | pubmed-meshheading:407151-I... | lld:pubmed |
| pubmed-article:407151 | pubmed:meshHeading | pubmed-meshheading:407151-M... | lld:pubmed |
| pubmed-article:407151 | pubmed:meshHeading | pubmed-meshheading:407151-M... | lld:pubmed |
| pubmed-article:407151 | pubmed:meshHeading | pubmed-meshheading:407151-C... | lld:pubmed |
| pubmed-article:407151 | pubmed:meshHeading | pubmed-meshheading:407151-I... | lld:pubmed |
| pubmed-article:407151 | pubmed:year | 1977 | lld:pubmed |
| pubmed-article:407151 | pubmed:articleTitle | Appearance of a variant of MOPC 104E which does not react with dextran B-1355s. | lld:pubmed |
| pubmed-article:407151 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:407151 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
